LivaNova (LIVN) Liabilities from Discontinued Operations (2016 - 2021)
LivaNova's (LIVN) quarterly Liabilities from Discontinued Operations came in at $27.1 million in Q1 2021, down 8.63% quarter-over-quarter from $29.7 million in Q4 2020.
Analysis
LivaNova (LIVN) Liabilities from Discontinued Operations (2016 - 2021) Analysis & Trends
LivaNova has disclosed Liabilities from Discontinued Operations across 5 years of filings, most recently posting $27.1 million for Q1 2021.
- In Q1 2021, Liabilities from Discontinued Operations changed N/A year-over-year to $27.1 million; the TTM figure through Mar 2021 stood at $27.1 million (changed N/A YoY), while the FY2020 annual figure was $29.7 million, changed N/A from the prior year.
- Liabilities from Discontinued Operations came in at $27.1 million for Q1 2021 at LivaNova, down from $29.7 million in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of $85.0 million in Q1 2018 to a low of $27.1 million in Q1 2021.
- Average Liabilities from Discontinued Operations over 4 years is $55.0 million, with a median of $53.9 million recorded in 2017.
- The largest YoY upside for Liabilities from Discontinued Operations was 6.21% in 2017 against a maximum downside of 6.21% in 2017.
- Over 4 years, Liabilities from Discontinued Operations stood at $78.1 million in 2017, then advanced by 8.86% to $85.0 million in 2018, then plunged by 65.08% to $29.7 million in 2020, then declined by 8.63% to $27.1 million in 2021.
- Per Business Quant data, the three most recent Liabilities from Discontinued Operations figures were $27.1 million in Q1 2021, $29.7 million in Q4 2020, and $85.0 million in Q1 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | LivaNova | 4.34 Bn | 3.82 Bn | 273.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2021 | 27.12 Mn |
| Dec 31, 2020 | 29.68 Mn |
| Mar 31, 2018 | 84.99 Mn |
| Dec 31, 2017 | 78.08 Mn |
| Dec 31, 2016 | 83.24 Mn |